Ms. Lee is a member of the firms Biotechnology/Pharmaceutical Group. She has extensive experience in prosecuting patent applications and writing opinions regarding patentability, infringement and freedom-to-operate. Ms. Lee’s work focuses on biotechnology area including nucleic acid and polypeptide sequences, antibodies, and pharmaceuticals, as well as advanced materials area. She has consulted clients in negotiating licensing and joint development agreements and conducted related due diligence. Patent portfolios that Ms. Lee helped the client to build and monetize include biotech platform technologies.
She was a member of the firm's litigation team for the recent AZ v. Hanmi in the District Court of New Jersey, which was the Korean drug companies' first US Hatch-Waxman litigation.
Ms. Lee is named in the 2015 Rising Stars within the Washington DC metropolitan area by the Washington DC Super Lawyers Magazine. She speaks fluent Korean and is a registered Korean Patent Attorney. Ms. Lee is a Korea Innovation Center (KIC) Washington DC leadership mentor. She also served as a president of the KAIPBA.